AIG
MYGN icon

American International Group’s Myriad Genetics MYGN Stock Holding History

American International Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,331
Closed -$1.01M – 1710
2024
Q1 		$1.01M Buy
47,331
+3,011
+7% +$64.7K ﹤0.01% 1293
2023
Q4 		$848K Sell
44,320
-53
-0.1% -$917 ﹤0.01% 1392
2023
Q3 		$712K Buy
44,373
+953
+2% +$18.1K ﹤0.01% 1413
2023
Q2 		$1.01M Sell
43,420
-90
-0.2% -$1.96K 0.01% 1251
2023
Q1 		$1.01M Buy
43,510
+181
+0.4% +$3.68K 0.01% 1210
2022
Q4 		$629K Sell
43,329
-314
-0.7% -$5.85K ﹤0.01% 1466
2022
Q3 		$833K Buy
43,643
+495
+1% +$11.4K 0.01% 1278
2022
Q2 		$784K Sell
43,148
-2,344
-5% -$48.7K 0.01% 1341
2022
Q1 		$1.15M Sell
45,492
-2,790
-6% -$71.4K 0.01% 1251
2021
Q4 		$1.33M Sell
48,282
-429
-0.9% -$12.4K 0.01% 1256
2021
Q3 		$1.57M Sell
48,711
-1,044
-2% -$34.7K 0.01% 1166
2021
Q2 		$1.52K Buy
49,755
+2,014
+4% +$58.2K 0.01% 1272
2021
Q1 		$1.45K Sell
47,741
-574
-1% -$16.3K 0.01% 1283
2020
Q4 		$955 Sell
48,315
-1,152
-2% -$18.6K ﹤0.01% 1405
2020
Q3 		$645K Sell
49,467
-1,206
-2% -$15.3K ﹤0.01% 1463
2020
Q2 		$575K Buy
50,673
+1,442
+3% +$20.5K ﹤0.01% 1525
2020
Q1 		$704K Sell
49,231
-2,433
-5% -$51.4K ﹤0.01% 1270
2019
Q4 		$1.41M Sell
51,664
-754
-1% -$20.7K 0.01% 1162
2019
Q3 		$1.5M Sell
52,418
-541
-1% -$15.8K 0.01% 1098
2019
Q2 		$1.47M Buy
52,959
+473
+0.9% +$13.4K 0.01% 1124
2019
Q1 		$1.74M Sell
52,486
-2,509
-5% -$76.4K 0.01% 1055
2018
Q4 		$1.6M Buy
54,995
+2,251
+4% +$81K 0.01% 1047
2018
Q3 		$2.43M Buy
52,744
+1,684
+3% +$74.9K 0.01% 971
2018
Q2 		$1.91M Buy
51,060
+9,319
+22% +$315K 0.01% 1041
2018
Q1 		$1.23M Sell
41,741
-10,653
-20% -$360K ﹤0.01% 1149
2017
Q4 		$1.8M Buy
52,394
+1,015
+2% +$34.2K 0.01% 1065
2017
Q3 		$1.86M Buy
51,379
+2,777
+6% +$79.2K 0.01% 1021
2017
Q2 		$1.26M Buy
48,602
+7,031
+17% +$149K ﹤0.01% 1155
2017
Q1 		$798K Buy
41,571
+2,747
+7% +$48.7K ﹤0.01% 1311
2016
Q4 		$647K Sell
38,824
-101
-0.3% -$1.83K ﹤0.01% 1479
2016
Q3 		$801K Buy
38,925
+59
+0.2% +$1.5K ﹤0.01% 1345
2016
Q2 		$1.19M Sell
38,866
-1,382
-3% -$48K 0.01% 1084
2016
Q1 		$1.51M Sell
40,248
-839
-2% -$31.6K 0.01% 1243
2015
Q4 		$1.77M Buy
41,087
+340
+0.8% +$14.4K 0.01% 1164
2015
Q3 		$1.53M Sell
40,747
-52
-0.1% -$1.85K 0.01% 1219
2015
Q2 		$1.39M Buy
40,799
+38,936
+2,090% +$1.32M 0.01% 1356
2015
Q1 		$66K Sell
1,863
-12
-0.6% -$430 ﹤0.01% 3829
2014
Q4 		$63.9K Sell
1,875
-2,389
-56% -$84.8K ﹤0.01% 3859
2014
Q3 		$164K Buy
4,264
+803
+23% +$30K ﹤0.01% 3139
2014
Q2 		$135K Sell
3,461
-663
-16% -$24.7K ﹤0.01% 3349
2014
Q1 		$141K Buy
4,124
+2,837
+220% +$87.9K ﹤0.01% 3163
2013
Q4 		$27K Sell
1,287
-1,237
-49% -$31.3K ﹤0.01% 4021
2013
Q3 		$59.3K Buy
2,524
+1,038
+70% +$29.5K ﹤0.01% 3643
2013
Q2 		$39.9K Buy
+1,486
New +$43.1K ﹤0.01% 3691

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American International Group's MYGN Position: Q2 2024 in Review

American International Group sold out of Myriad Genetics (MYGN) in Q2 2024, closing a stake of 47,331 shares — an estimated $1.01M sold.

American International Group first reported a position in MYGN in Q2 2013 and held it in 44 quarters. The position peaked at $2.43M in Q3 2018. 223 funds tracked by Wall St. Rank hold MYGN as of Q2 2024.

  • American International Group reported no remaining Myriad Genetics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 47,331 Myriad Genetics shares in Q2 2024, an estimated $1.01M.
  • American International Group first reported a position in Myriad Genetics in Q2 2013 and held it in 44 quarters.
  • American International Group's Myriad Genetics position peaked at $2.43M in Q3 2018.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.